Suppr超能文献

结直肠癌中核因子活化 T 细胞细胞质 2(NFATc2)和过氧化物酶体增殖物激活受体 γ(PPARG)转录因子的 mRNA 表达。

mRNA expression of nuclear factor of activated T-cells, cytoplasmic 2 (NFATc2) and peroxisome proliferator-activated receptor gamma (PPARG) transcription factors in colorectal carcinoma.

机构信息

Department of Biochemistry and Clinical Laboratories, Division of Medical Genetics, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran; Tuberculosis and Lung Disease Research Center of Tabriz University of Medical Sciences, Tabriz, Iran.

出版信息

Bosn J Basic Med Sci. 2017 Aug 20;17(3):255-261. doi: 10.17305/bjbms.2017.1886.

Abstract

Transcription factors are involved in cell cycle and apoptosis regulation and thus have a key role in the carcinogenesis of different tumors. Nuclear factor of activated T-cells, cytoplasmic 2 (NFATc2) and peroxisome proliferator-activated receptor gamma (PPARG) transcription factors are important in the carcinogenesis of colorectal cancer (CRC). In this study, we examined whether the expression of NFATc2 and PPARG genes is significantly altered during the carcinogenesis of CRC. A total of 47 tumor samples and matched normal tissue margins were collected during surgery from patients with CRC. In addition, three CRC cell lines (HCT119, SW480, and HT29) and healthy cell line were used. After total RNA extraction and cDNA synthesis, mRNA expression levels of NFATc2 and PPARG were examined by real-time polymerase chain reaction. The results showed that NFATc2 is overexpressed in the tumor tissues compared with normal tissue margins (p ≤ 0.05). However, the mRNA expression levels of PPARG were not significantly different between the tumor tissues and tissue margins. Our results indicate that NFATc2 may be used as an early diagnostic or predictive biomarker for CRC as well as a therapeutic target, providing that upcoming studies confirm these results.

摘要

转录因子参与细胞周期和细胞凋亡的调控,因此在不同肿瘤的发生中起着关键作用。活化 T 细胞核因子、胞浆 2(NFATc2)和过氧化物酶体增殖物激活受体γ(PPARG)转录因子在结直肠癌(CRC)的发生中起着重要作用。在本研究中,我们研究了 NFATc2 和 PPARG 基因的表达是否在 CRC 的发生过程中发生显著改变。我们在手术中从 CRC 患者收集了总共 47 个肿瘤样本和匹配的正常组织边缘。此外,我们还使用了三个 CRC 细胞系(HCT119、SW480 和 HT29)和健康细胞系。提取总 RNA 并合成 cDNA 后,通过实时聚合酶链反应检测 NFATc2 和 PPARG 的 mRNA 表达水平。结果表明,与正常组织边缘相比,肿瘤组织中 NFATc2 过度表达(p ≤ 0.05)。然而,肿瘤组织和组织边缘之间的 PPARG mRNA 表达水平没有显著差异。我们的结果表明,NFATc2 可以作为 CRC 的早期诊断或预测生物标志物以及治疗靶点,前提是即将进行的研究能够证实这些结果。

相似文献

2
Peroxisome proliferator-activated receptor γ-mediated induction of microRNA-145 opposes tumor phenotype in colorectal cancer.
Biochim Biophys Acta. 2014 Jun;1843(6):1225-36. doi: 10.1016/j.bbamcr.2014.03.003. Epub 2014 Mar 11.
3
A key regulatory role of the transcription factor NFATc2 in bronchial adenocarcinoma via CD8+ T lymphocytes.
Cancer Res. 2009 Apr 1;69(7):3069-76. doi: 10.1158/0008-5472.CAN-08-1678. Epub 2009 Mar 24.
4
Interplay between SOX9, β-catenin and PPARγ activation in colorectal cancer.
Biochim Biophys Acta. 2013 Aug;1833(8):1853-65. doi: 10.1016/j.bbamcr.2013.04.004. Epub 2013 Apr 11.
9
Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.
Gastroenterology. 2013 Sep;145(3):647-57.e15. doi: 10.1053/j.gastro.2013.05.011. Epub 2013 May 15.

引用本文的文献

1
Serum Level of MVIH, HNF1A-AS1, and NEAT1 Long Noncoding RNAs: Potential Biomarkers for Colorectal Cancer.
Asian Pac J Cancer Prev. 2025 Jun 1;26(6):1953-1958. doi: 10.31557/APJCP.2025.26.6.1953.
2
Nuclear Factor of Activated T Cells (NFAT) Proteins as Targeted Molecules in Diseases: A Narrative Review.
Cureus. 2024 Dec 16;16(12):e75844. doi: 10.7759/cureus.75844. eCollection 2024 Dec.
3
Wearable Device for Cumulative Chlorobenzene Detection and Accessible Mitigation Strategies.
Sensors (Basel). 2023 Sep 15;23(18):7904. doi: 10.3390/s23187904.
7
Antitumor pharmacotherapy of colorectal cancer in kidney transplant recipients.
Ther Adv Med Oncol. 2019 Sep 23;11:1758835919876196. doi: 10.1177/1758835919876196. eCollection 2019.
8
NFATC2 is a novel therapeutic target for colorectal cancer stem cells.
Onco Targets Ther. 2018 Oct 15;11:6911-6924. doi: 10.2147/OTT.S169129. eCollection 2018.

本文引用的文献

1
Clinical utility of measuring expression levels of Stanniocalcin 2 in patients with colorectal cancer.
Med Oncol. 2014 Oct;31(10):237. doi: 10.1007/s12032-014-0237-8. Epub 2014 Sep 19.
3
Emerging role of the β-catenin-PPARγ axis in the pathogenesis of colorectal cancer.
World J Gastroenterol. 2014 Jun 21;20(23):7137-51. doi: 10.3748/wjg.v20.i23.7137.
4
Nuclear factor of activated T cells - a transcription factor family as critical regulator in lung and colon cancer.
Int J Cancer. 2014 Apr 15;134(8):1767-75. doi: 10.1002/ijc.28329. Epub 2013 Jul 24.
5
NFAT1 is highly expressed in, and regulates the invasion of, glioblastoma multiforme cells.
PLoS One. 2013 Jun 6;8(6):e66008. doi: 10.1371/journal.pone.0066008. Print 2013.
6
Interplay between SOX9, β-catenin and PPARγ activation in colorectal cancer.
Biochim Biophys Acta. 2013 Aug;1833(8):1853-65. doi: 10.1016/j.bbamcr.2013.04.004. Epub 2013 Apr 11.
7
PPARG Epigenetic Deregulation and Its Role in Colorectal Tumorigenesis.
PPAR Res. 2012;2012:687492. doi: 10.1155/2012/687492. Epub 2012 Jul 16.
8
Transcription factor NFATc2 controls the emergence of colon cancer associated with IL-6-dependent colitis.
Cancer Res. 2012 Sep 1;72(17):4340-50. doi: 10.1158/0008-5472.CAN-11-4155. Epub 2012 Jun 27.
9
Restricted heterochromatin formation links NFATc2 repressor activity with growth promotion in pancreatic cancer.
Gastroenterology. 2012 Feb;142(2):388-98.e1-7. doi: 10.1053/j.gastro.2011.11.001. Epub 2011 Nov 10.
10
Biological function and prognostic significance of peroxisome proliferator-activated receptor δ in rectal cancer.
Clin Cancer Res. 2011 Jun 1;17(11):3760-70. doi: 10.1158/1078-0432.CCR-10-2779. Epub 2011 Apr 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验